Elite Pharmaceuticals ELTP
OTC ELTP
$0.24 +0.00 (+0.00%)
As of: Oct 21, 2026 · 11:00 AM EDT

Elite Pharmaceuticals (ELTP) Long-Term Debt Issuances (2020 - 2023)

Updated

Elite Pharmaceuticals' Long-Term Debt Issuances came in at $4 million for FY2024 (year ended Mar 31, 2024), down 72.3% from $14.44 million in FY2023.

Analysis

Elite Pharmaceuticals (ELTP) Long-Term Debt Issuances (2020 - 2023) Analysis & Trends

  • The FY2024 figure represents the lowest annual Long-Term Debt Issuances since FY2021.
  • Per Business Quant, earlier fiscal years put Long-Term Debt Issuances at $14.44 million in FY2023 and -$1.2 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,164.36 Bn 1,132.95 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 634.54 Bn 553.07 Bn 17.26 Bn -
3 AbbVie 502.85 Bn 475.96 Bn 12.70 Bn -
4 Merck 376.50 Bn 330.88 Bn 12.21 Bn -
5 Novartis Ag 303.65 Bn 267.64 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 266.62 Bn 240.30 Bn 12.86 Bn -
7 Amgen 241.17 Bn 196.57 Bn 7.24 Bn -
8 Gilead Sciences 193.39 Bn 167.59 Bn 6.22 Bn -
9 Pfizer 172.45 Bn 119.10 Bn 10.94 Bn -
10 Elite Pharmaceuticals 263.92 Mn 145.59 Mn 13.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 4.00 Mn
Mar 31, 2023 -111,016.00
Dec 31, 2022 1.00
Sep 30, 2022 2.55 Mn
Jun 30, 2022 12.00 Mn
Mar 31, 2021 -1.20 Mn
Jun 30, 2020 1.01 Mn
API Access

Elite Pharmaceuticals Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=ELTP&period=max&api_key=YOUR_API_KEY